Rate My Professor Rick Reisdorph

Reisdorph's academic interests center on developing quantitative metabolomics and proteomics techniques and bioinformatics approaches. In his role at the Mass Spectrometry Core Facility, established in 2007 and expanded with the Reisdorph Lab in 2015, he facilitates advanced services including proteomics analyses such as BCA protein assay, C18 cleanup, preomics, acetylomics, skin taping, in-gel digest, various in-solution digests, ID gel, 2D gel, LC proteomics, accurate mass determination, and HPLC. Metabolomics offerings include immunodepletion, methanol extraction, MTBE liquid-liquid extraction, and targeted assays for acylcarnitines, amino acids, oxylipins, nucleotides, bile acids, endocannabinoids, leukotriene E4, PAHs, steroid hormones, 25-OH vitamin D2/D3, FAMES, and TCA cycle metabolites. The facility features instrumentation like multiple LC-MS/MS systems, Orbitrap, GC-MS, and supports sample preparation training, hands-on workshops in metabolomics and proteomics, data analysis, collaborations with academic and industrial partners across Colorado and nationwide, and grant support including letters of collaboration. Reisdorph has contributed to publications including "A Perspective and Framework for Developing Sample Type Specific Databases for LC/MS-Based Clinical Metabolomics" (2019), "Quantitation of peptides from non-invasive skin tapings using proteomics" (2018), "A prototypic small molecule database for bronchoalveolar lavage fluid" (2018), and "Customized Consensus Spectral Library Building for Social and Epidemiologic Applications of Untargeted Metabolomics" (2017).